7A21--IDS (Investigational Drug System) Software 36C26026Q0548
Summary
AI-generated · Apr 11, 2026A secure, HIPAA- and 21 CFR Part 11–compliant, web-based Investigational Drug System (IDS) is sought to automate the management of the VAPSHCS Investigational Drug Service. The IDS must handle all drug transactions (receive, transfer, dispense, return to supplier, destroy, and adjustments), maintain a comprehensive catalog of drugs, protocols, patients, suppliers, documents, and pharmacies, and generate auditable accountability logs exportable to formats used in audits (e.g., NCI DARF, NCI ORAL DRAF, ACTG, and de-identified variants). It should support granular inventory tracking to individual bottles/vials/kits, patient-specific drug tracking, double-signature verification, barcoded labels, physical inventory monitoring, par level management, and pharmacy billing.
The system should operate as a standalone solution but offer interfaces to CTMS, EMR, and IRB systems for protocol, patient, and document management; integrate with inpatient/outpatient pharmacy systems for inventory deductions and dispense logging; and support inventory movement between locations via carousels. It must provide multi-site compatibility, role-based access, and robust audit trails, and be accessible to staff at the Seattle and American Lake Divisions of VAPSHCS. This is a sources-sought notice to gather information; responses are voluntary, non-binding, and the government will not pay for information. If a solicitation is issued, it will be posted on SAM.gov or GSA.
DISCLAIMER: THIS IS A SOURCE SOUGHT NOTICE ONLY. THIS SYNOPSIS IS NOT A REQUEST FOR QUOTE, PROPOSAL, OR BID. This notice is not a solicitation as defined by FAR 2.101, therefore it shall not be construed as a commitment by the Government to enter into a contract, nor does it restrict the Government to an acquisition approach. All information contained in this RFI is preliminary as well as subject to modification and is in no way binding on the Government. Information submitted in response to this notice is voluntary; the Government will not pay for information requested nor will it compensate any respondent for any cost incurred in developing information provided to the Government. The Government is requesting that restrictive or proprietary markings not be used in response to this notice. If a solicitation is released, it will be synopsized on the SAM.gov or GSA. It is the responsibility of the interested parties to monitor these sites for additional information pertaining to this RFI. STATEMENT OF WORK: Investigational Drug System (IDS); automation software to aid in the management of VAPSHCS s investigational drug service. Vendor shall provide IDS, a secure, HIPAA and 21 CFR Part 11 compliant, web-based application that has the following features: Monitors Receive, Transfer, Dispense, Return to Supplier, Destroy, and Adjustment transactions Manages a comprehensive drug catalog, protocols, patients, suppliers, documents, and pharmacies Generates accountability logs exportable to NCI DARF, NCI ORAL DRAF, ACTG, De-Identified and other format, significantly facilitating the audit process Granular inventory tracking down to an individual Bottle, Vial, or Kit # Patient-specific drug tracking Double signature verification Barcoded inventory labels Physical inventory monitoring Par level management Pharmacy billing Operates as a standalone system but has interfaces available to reduce data entry, including CTMS, EMR, and IRB systems for protocol, patient, and document management; inpatient or outpatient pharmacy systems for deducting inventory and logging dispenses; and carousels for inventory movement between locations Comprehensive coverage of all inventory transactions performed with investigational drugs Simplifies preparation for monitor visits and audits Ensures dispensing accuracy by tracking a patient s dispensing history, treatment arms, expiration, and patient-specific inventory Print patient labels and record inventory deduction on logs in a single dispense transaction Supports multi-site pharmacy systems and allows users to sign into specific dispensing locations Minimize workflow errors with role-based access HIPAA and 21 CFR Part 11 compliant (including audit trail logging) IDS will be accessible to staff at the Seattle and American Lake Divisions of VAPSHCS.
From Sources Sought posted on Apr 10, 2026Notice history
1Details
Award Information
Contacts
Jeffrey Kelley
Agency
Place of Performance
Seattle, WA 98108-1532
USA